PDA

View Full Version : Myriad Applauds New ACOG Guidelines For Hereditary Breast And Ovarian Cancer


News
03-26-2009, 03:12 AM
Myriad Genetics, Inc. (NASDAQ: MYGN) announced its support of The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin Number 103, dated April 2009, which sets forth ACOG's clinical management guidelines for obstetricians and gynecologists.

More... (http://www.medicalnewstoday.com/articles/143653.php)